Automated immunoassay analyzer BKI2200

for clinical diagnosticchemiluminescence immunoassaychemiluminescence

Introduction
The BKI2200 chemiluminescence immunoassay system uses magnetic particle separation with magnetic particles as antibody carriers to ensure uniform distribution in liquid-phase reactions, delivering faster reaction kinetics and increased efficiency. It applies tubular enzymatic chemiluminescence with next-generation enzymatic substrates for improved sensitivity and stable luminescent signal.

Key specifications

• Brand: BIOBASE
• Product origin: CHINA
• Delivery time: Within 7 days
• Supply capacity: Factory Direct Supply
• Model: BKI2200
• Maximum throughput: 240 tests/hour
• Footprint: ~0.68 m²

Advantages

• 1. Operation Module: Tubular enzymatic chemiluminescence with magnetic particle separation; single-unit maximum speed up to 240 tests/h; carrier contamination rate <10^-5; intra-batch precision ≤8%.
• 2. Control Module: Ergonomic layout for operator comfort; compact patented design occupying approximately 0.68 m²; supports bidirectional LIS communication and barcode scanning; integrated touchscreen and frame; real-time online loading of consumables.
• 3. System Layout: Integrated automated layout engineered for streamlined workflow, safe sample and reagent handling, and minimized cross-contamination.
• 4. Instrument Software Module: User-friendly software for intuitive reagent loading and sample operation; real-time sample status display; result review by sample or by project; accurate reagent usage logging per project and remaining consumable monitoring with low-consumable alarms; simple QC workflow with T-P and L-J chart support; categorized maintenance tasks (daily, monthly, yearly).

Technical Parameters
Thyroid: TSH, TT4, TT3, FT4, FT3, TgAb, TPOAb, TG, Anti-TSHR
Fertility: β-HCG, E2, P, T, PRL, FSH, LH, DHEA-S, SHBG, AMH
Hypertension: ALD, ACTH, Cortisol, Renin, AII*
Tumor markers: CA125, CA15-3, CA19-9, AFP, CEA, 1-PSA, CA72-4, SCC, CA242, CA50, NSE, CYFRA21-1, HE4, ProGRP
Cardiac markers: cTnI, NT-proBNP, CK-MB, MYO

Reagent Menu
Renal function: β2-MG
Rheumatoid: Anti-CCP
Liver fibrosis: CIV, HA, PⅢINP, LN
Anemia: FA, VB12, FERRITIN
Growth: GH, IGF-I*
Glycometabolism: INS, C-P
Pepsinogen: PGI, PGII
Inflammation: PCT, IL-6
Early screening: FE3, Free β-HCG, PAPP-A
Bone metabolism: BGP, 25-OH-Vit-D, iPTH, PINP*, CT
Infectious: HBeAb*, HBeAg*, HBcAb*, HBsAb*, HBsAg*, Anti-HBc IgM*, HIV Ag/Ab*, Anti-TP*, Anti-HCV*

Characteristics / technical specifications

• Assay principle: Tubular enzymatic chemiluminescence with magnetic particle separation.
• Maximum throughput: up to 240 tests/hour (depending on configuration).
• Carrier contamination rate: <10^-5.
• Precision: intra-batch precision ≤8%.
• Footprint: highly integrated patented design occupying approximately 0.68 m².
• Connectivity: supports bidirectional LIS communication and barcode scanning.
• User interface: integrated touchscreen with intuitive sample-status display and result review.
• Consumables management: online real-time loading, per-project reagent usage logging, remaining quantity monitoring and low-consumable alarms.
• Quality control: easy QC addition, intuitive QC result display, support for T-P and L-J charts.
• Maintenance: structured maintenance program with selectable daily, monthly and yearly tasks.
• Reagent coverage: broad menu including thyroid, fertility, tumor markers, cardiac markers, renal, inflammation, liver fibrosis, anemia, growth, glycometabolism, pepsinogen, bone metabolism and infectious disease panels.